We are live on ! Find out more
PRME icon

Prime Medicine
PRME

79 hedge funds and large institutions have $676M invested in Prime Medicine in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 13 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

177% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 13

32% more capital invested

Capital invested by funds: $512M → $676M (+$164M)

23% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 13

4.53% more ownership

Funds ownership: 42.92% → 47.45% (+4.5%)

4% more funds holding

Funds holding: 76 → 79 (+3)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
79
Holders Change
+3
Holders Change %
+3.95%
% of All Funds
1.24%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
16
Increased
36
Reduced
13
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$34.2M
2
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$28.8M
3
NAMA
Nikko Asset Management Americas
New York
+$28.8M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$20M
5
BlackRock
BlackRock
New York
+$19.2M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$62.5M
2
AI
Alphabet Inc
California
-$19.9M
3
RG
Redmile Group
California
-$9.33M
4
CAM
Cormorant Asset Management
Massachusetts
-$9.03M
5
CC
Casdin Capital
New York
-$5.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
MPWT
76
MassMutual Private Wealth & Trust
Connecticut
$498 +$475 +34 New
Nisa Investment Advisors
77
Nisa Investment Advisors
Missouri
$483 +$461 +33 New
CAM
78
Cormorant Asset Management
Massachusetts
– -$9.03M -734,350 Closed
WC
79
Wexford Capital
Florida
– -$1.89M -153,705 Closed
OMC
80
OUP Management Company
Pennsylvania
– -$1.49M -121,255 Closed
Swiss National Bank
81
Swiss National Bank
Switzerland
– -$515K -41,900 Closed
JF
82
Jump Financial
Illinois
– -$400K -32,500 Closed
PAM
83
Panagora Asset Management
Massachusetts
– -$396K -32,197 Closed
CSS
84
Cubist Systematic Strategies
Connecticut
– -$242K -19,663 Closed
State of Wisconsin Investment Board
85
State of Wisconsin Investment Board
Wisconsin
– -$221K -17,999 Closed
CS
86
Credit Suisse
Switzerland
– -$181K -14,705 Closed
Capstone Investment Advisors
87
Capstone Investment Advisors
New York
– -$179K -14,551 Closed
SO
88
STRS Ohio
Ohio
– -$29K -2,400 Closed
TWA
89
TCI Wealth Advisors
Arizona
– -$2.84K -231 Closed
Federated Hermes
90
Federated Hermes
Pennsylvania
– -$554 -45 Closed
1 2 3
4

PRME Hedge Fund Activity: Q2 2023 in Review

79 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Prime Medicine (PRME) for Q2 2023, worth a combined $676M — up 32% from $512M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new PRME positions and 13 closed out — a net gain of 3 holders — while 36 added to existing stakes and 13 trimmed.

The largest buyer was Vanguard Group, adding an estimated $34.2M. The largest seller was Fidelity Investments, cutting an estimated $62.5M.

  • 79 institutional investors held Prime Medicine (PRME) as of Q2 2023, up from 76 in Q1 2023.
  • Funds reported $676M of Prime Medicine stock for Q2 2023, up 32% quarter-over-quarter.
  • 16 funds opened new Prime Medicine positions in Q2 2023 and 13 closed out, a net change of +3 holders.
  • The largest Prime Medicine buyer in Q2 2023 was Vanguard Group, an estimated $34.2M added.
  • The largest Prime Medicine seller in Q2 2023 was Fidelity Investments, an estimated $62.5M sold.

Based on aggregated 13F filings for Q2 2023.